Directory
>
Anjali Shukla
Anjali Shukla
Review Chief/Supervisor | FDA
Washington, District of Columbia, United States
Anjali Shukla
Summary
Dr. Anjali Shukla is a distinguished Review Chief at the FDA's Division of Biotechnology Review and Research II, where she leverages her extensive expertise in cancer biology and biotechnology to ensure the efficacy and safety of biologic products. With a Ph.D. from Jawaharlal Nehru University, she has made significant contributions to the field of cancer research, particularly in biomarker discovery and the regulatory assessment of biotechnology products. Anjali has held various leadership roles at the FDA and NIH, demonstrating her ability to navigate complex regulatory landscapes while fostering innovation in cancer therapeutics. Her work has been recognized with multiple awards, including the NIH Fellows Award for Research Excellence and the NCI Director's Intramural Innovation Award. Anjali is not only a scientist but also a mentor, having supervised numerous trainees and interns in her field. Her passion for advancing scientific knowledge is evident in her published research and active participation in scientific communities. Outside of her professional pursuits, she is committed to promoting diversity and inclusion in the scientific workforce.
Anjali Shukla
Work Experience
Review Chief/Supervisor at
FDA
August 2023 - Present
Team Lead- Biologics CMC at
FDA
March 2020 - August 2023
Biotechnology Products CMC Assessor at
Us Food And Drug Administration
September 2016 - February 2020
Staff Scientist at
The National Institutes of Health
May 2013 - August 2016
Research Fellow at
The National Institutes of Health
April 2009 - May 2013
Anjali Shukla
Education
Jawaharlal Nehru University, Ph.D.
Frequently Asked Questions about Anjali Shukla
What company does Anjali Shukla work for?
Anjali Shukla is a Review Chief/Supervisor at FDA, a company specializing in General government, nec.
Where Anjali Shukla graduated from?
Anjali Shukla holds a degree in Cancer Biology from Jawaharlal Nehru University.
Who is Anjali Shukla?
Dr. Anjali Shukla is a distinguished Review Chief at the FDA's Division of Biotechnology Review and Research II, where she leverages her extensive expertise in cancer biology and biotechnology to ensure the efficacy and safety of biologic products. With a Ph.D. from Jawaharlal Nehru University, she has made significant contributions to the field of cancer research, particularly in biomarker discovery and the regulatory assessment of biotechnology products. Anjali has held various leadership roles at the FDA and NIH, demonstrating her ability to navigate complex regulatory landscapes while fostering innovation in cancer therapeutics. Her work has been recognized with multiple awards, including the NIH Fellows Award for Research Excellence and the NCI Director's Intramural Innovation Award. Anjali is not only a scientist but also a mentor, having supervised numerous trainees and interns in her field. Her passion for advancing scientific knowledge is evident in her published research and active participation in scientific communities. Outside of her professional pursuits, she is committed to promoting diversity and inclusion in the scientific workforce.
Anjali`s contact details
Colleagues
Branch Chief
Branch Chief
Associate Chief Counsel
Chief, Tumor Vaccine and Biotechnology Branch
Chief Medical Officer
Supervisory Veterinary Medical Officer at FDA
Branch Chief, Compounding Incidents
Board of Dirctors
Acting Chief, NIVTB
Branch Chief, Neurostimulation Devices Psychiatry Branch